ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.
ST. LOUIS--(BUSINESS WIRE)--Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, today announced a strategic collaboration with Labcorp ...
BURLINGTON, N.C. and ST. LOUIS, June 22, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide availability of ...
Add Yahoo as a preferred source to see more of our stories on Google. A pedestrian walks by a LabCorp office on February 11, 2021, in Greenbrae, California. Labcorp has made the colorectal cancer ...
WASHINGTON (AP) — In a story March 24 about colon cancer screening tests, The Associated Press reported erroneously that the Colosure test from LabCorp is approved by the Food and Drug Administration.
A next-generation multitarget stool DNA test, including assessments of DNA molecular markers and hemoglobin level, was developed to improve the performance of colorectal cancer screening, primarily ...
Labcorp is a global life sciences company headquartered in Burlington, North Carolina. Labcorp provides at-home test kits as well as in-person testing at their laboratory facilities, which are located ...
Pixel by Labcorp is a service offering various at-home and in-person tests for different health conditions. The tests come with step-by-step instructions, and the company works with independent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results